HHS-NIH-NIAID-BAA2019-1: Research Area 002, Development of Therapeutic Products for Antibiotic Resistant Bacteria
Award Notice Posted
- Solicitation number
- HHS-NIH-NIAID-BAA2019-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Revagenix Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93020C00018 Federal contract award
Notice details come from SAM.gov. Updated .
About this opportunity
REVAGENIX, INC. was awarded a $2,040,178 contract by the National Institute of Allergy and Infectious Diseases (NIAID) to support development of therapeutic products for antibiotic resistant bacteria under Broad Agency Announcement HHS-NIH-NIAID-BAA2019-1, Research Area 002. The contract awarded on June 29, 2020 by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases will provide funding toward the stated goal of Research Area 002 of developing therapeutic products for antibiotic resistant bacteria, without specifying quantities or timelines.
Notice text
Awarded contract 75N93020C00018 to REVAGENIX, INC. for 20401780.00 on 2020-06-29.
Notice history
| Notice | Type | Posted |
|---|---|---|
| HHS-NIH-NIAID-BAA2019-1: Research Area 003, Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria | Award Notice | |
| HHS-NIH-NIAID-BAA2019-1: Research Area 003, Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria | Award Notice | |
| HHS-NIH-NIAID-BAA2019-1: Research Area 002, Development of Therapeutic Products for Antibiotic Resistant Bacteria | Award Notice | |
| This notice | Award Notice | |
| 2019 NIAID Omnibus Broad Agency Announcement | Pre-Solicitation | |
| 2019 NIAID Omnibus Broad Agency Announcement | Special Notice |
6 of 11 notices listed here. See the rest on GovTribe.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity